Drugmakers Secure $2.1 Billion Vaccine Deal With U.S.

More than a quarter-million people in the United States have died of COVID-19 as new coronavirus cases topped 180-thousand on Thursday. Jennifer Haythe, Cardiologist at Columbia University Irving Medical Center breaks down a timeline for vaccination and concerns over increased coronavirus testing.

Early data from Pfizer shows its coronavirus vaccine is more than 90% effective. The drugmaker analyzed the first 94 confirmed cases of covid-19 among its more than 43,000 volunteers and found less than 10% of those infections were among the people given two doses of the vaccine instead of a placebo. In terms of distribution, there is one major challenge: the vaccine must be stored at super-cold temperatures, which could make it extremely difficult to deliver to the masses. Damian Garde, National Biotech Reporter at Stat News, joined Wake Up With Cheddar to discuss.

Early data from Pfizer shows its coronavirus vaccine is more than 90% effective. But in terms of distribution, there is one major challenge. The vaccine must be stored at super-cold temperatures, which could make it extremely difficult to deliver to the public. For more on a potential rollout of the vaccine, we spoke to Damian Garde, National Biotech Reporter at Stat.